You are here: Home » Economy & Policy » News
Business Standard

India seeks new preferential treatment from US on drugs, other goods

India accounts for 40 per cent of US generic drug imports, including the anti-malarial hydroxychloroquine, touted by US President Donald Trump in the fight against Covid-19.

Topics
Hydroxychloroquine | Coronavirus | Indian pharma companies

Reuters  |  New Delhi 

India is seeking concessions for generic drugs it exports to the US in return for opening its dairy markets and slashing tariffs on farm goods as the two sides seek to shore up a new trade deal, three sources said. India accounts for 40 per cent of US generic drug imports, including the anti-malarial hydroxychloroquine, touted by US President Donald Trump in the fight against Covid-19. To win preferential treatment on pharmaceutical exports, the government of Prime Minister Narendra Modi is dangling the carrot of opening its dairy and farm markets to the Trump administration, ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Tue, July 21 2020. 00:55 IST
RECOMMENDED FOR YOU
.